drugset / Trial / NCT02268448
Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve Function
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of oral clonidine in subjects with symptomatic atopic dermatitis and to assess the safety and efficacy of oral naltrexone in subjects with symptomatic atopic dermatitis.
Timeline
- Start
- 2015-07
- Primary completion
- 2022-09
- Completion
- 2022-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonidine | Other / unclassified | 0.1 mg | Oral |
| Subject | Naltrexone | Small molecule | 50 mg | Oral |